Related Experiment Video
Updated: Jun 14, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Usefulness of factor V Leiden mutation testing in clinical practice
Ellen Ø Blinkenberg1, Ann-Helen Kristoffersen, Sverre Sandberg
1Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway. ellen.okland.blinkenberg@helse-bergen.no
The activated protein C resistance (APCR) and factor V Leiden mutation (FVL) test has low clinical usefulness. Many tests are ordered without clear indications, potentially leading to patient harm due to unwarranted advice.
Area of Science:
- Medical Diagnostics
- Clinical Genetics
- Hematology
Background:
- The activated protein C resistance (APCR) and factor V Leiden mutation (FVL) test are used to assess thrombophilia risk.
- Understanding the clinical utility and physician practices surrounding APCR/FVL testing is crucial for optimizing diagnostic strategies.
Purpose of the Study:
- To investigate the clinical usefulness of APCR/FVL testing in Norway.
- To examine the indications for testing, patient follow-up, and variations in testing practices among physicians.
Main Methods:
- A questionnaire survey was distributed to Norwegian physicians ordering APCR/FVL tests.
- Response rate was 70% (267/383).
- Data analyzed included test indications, patient history, and physician-reported follow-up actions.
Main Results:
- 46% of tests were predictive (risk assessment in healthy individuals), with 42% patient-initiated and 24% for oral contraceptive screening.
- 54% of tests were diagnostic (for patients with VTE, stroke, or myocardial infarction history).
- Prevalence of FVL heterozygotes was similar in predictive (26%) and diagnostic (20%) groups. Only predictive tests influenced patient follow-up, and normal results sometimes led to unwarranted advice against antithrombotic measures.
Conclusions:
- The clinical usefulness of APCR/FVL testing is generally low, with many tests ordered for unsubstantiated indications.
- Physician advice and patient management can be negatively impacted by test results, particularly normal findings, potentially causing patient harm.
- Recommendations for more judicious use of APCR/FVL testing are warranted.
Related Concept Videos
In vitro Mutagenesis
Mutations in Microorganisms
In-vitro Mutagenesis
Spontaneous and Induced Mutations
Point and Frameshift Mutations
Compacting Factor test
The procedure begins by placing concrete into the upper hopper without any compaction. Once filled, the bottom door of this hopper is opened,...

